HighTower Advisors’s Chimerix, Inc. CMRX Stock Holding History

HighTower Advisors’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,259	Closed	-$19K	–	4078
2023 Q4	$19K	Sell	19,259 -1,000	-5%	-$968	﹤0.01%	3400
2023 Q3	$20K	Hold	20,259	–	–	﹤0.01%	3330
2023 Q2	$25K	Hold	20,259	–	–	﹤0.01%	3235
2023 Q1	$25K	Hold	20,259	–	–	﹤0.01%	3129
2022 Q4	$37K	Sell	20,259 -2,750	-12%	-$5.38K	﹤0.01%	3073
2022 Q3	$45K	Sell	23,009 -7,000	-23%	-$15.7K	﹤0.01%	2896
2022 Q2	$62K	Hold	30,009	–	–	﹤0.01%	2879
2022 Q1	$137K	Hold	30,009	–	–	﹤0.01%	2922
2021 Q4	$192K	Buy	30,009 +18,000	+150%	+$108K	﹤0.01%	2792
2021 Q3	$74K	Buy	+12,009	New	+$82.6K	﹤0.01%	2888
2021 Q1	–	Sell	-12,009	Closed	-$58K	–	3293
2020 Q4	$58K	Buy	+12,009	New	+$43.5K	﹤0.01%	2396

Other funds holding CMRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HighTower Advisors's CMRX Position: Q1 2024 in Review

HighTower Advisors sold out of Chimerix, Inc. (CMRX) in Q1 2024, closing a stake of 19,259 shares — an estimated $19K sold.

HighTower Advisors first reported a position in CMRX in Q4 2020 and held it in 11 quarters. The position peaked at $192K in Q4 2021. 78 funds tracked by Wall St. Rank hold CMRX as of Q1 2024.

HighTower Advisors reported no remaining Chimerix, Inc. position as of Q1 2024 after selling out during the quarter.
HighTower Advisors sold 19,259 Chimerix, Inc. shares in Q1 2024, an estimated $19K.
HighTower Advisors first reported a position in Chimerix, Inc. in Q4 2020 and held it in 11 quarters.
HighTower Advisors's Chimerix, Inc. position peaked at $192K in Q4 2021.
78 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.